DrugDashboards

Dextrose

Dextrose · DEXTROSE MONOHYDRATE 50 mg/mL · Injection, Solution · Intravenous · B. Braun Medical Inc.

NDC 00264-1510-31 · 84 CONTAINER in 1 CASE / 50 mL in 1 CONTAINER · NDA · View full market →

The short version

5 companies supply this market — a reasonable cushion if one runs into trouble. It is in shortage right now.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$2.47
Reported to Texas DSHS · 2026 annual filing · B. Braun Medical Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$77,439
6,954 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA016730
TE code
AP
Approval date
Jan 1, 1982
Patents / exclusivity
None on file

Shortage history

  • In shortage now DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7918-19)Oct 11, 2024
    month 23 of a typical 20 for injectable shortages
  • In shortage now Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 0264-1510-31)Feb 14, 2022
    month 55 — 3× the typical 20-month injectable shortage
  • In shortage now Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 0264-1510-32)Feb 14, 2022
    month 55 — 3× the typical 20-month injectable shortage

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Dextrose (Injection, Solution)

LabelerStrengthFirst seenLast seen
B. Braun Medical Inc.DEXTROSE MONOHYDRATE 50 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.DEXTROSE MONOHYDRATE 250 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstDEXTROSE MONOHYDRATE 25 g/50mLJul 15, 2026Sep 2, 2026
HF Acquisition Co. LLC. DBA HealthFirstDEXTROSE MONOHYDRATE 100 mg/mLJul 15, 2026Sep 2, 2026
ICU Medical Inc.DEXTROSE MONOHYDRATE 50 g/100mLJul 15, 2026Sep 2, 2026
ICU Medical Inc.DEXTROSE MONOHYDRATE 70 g/100mLJul 15, 2026Sep 2, 2026
ICU Medical Inc.DEXTROSE MONOHYDRATE 20 g/100mLJul 15, 2026Sep 2, 2026
ICU Medical Inc.DEXTROSE MONOHYDRATE 30 g/100mLJul 15, 2026Sep 2, 2026
ICU Medical Inc.DEXTROSE MONOHYDRATE 40 g/100mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Dextrose — NDC 00264-1510-31," retrieved September 3, 2026, https://drugdashboards.com/drug/00264151031.

Free to cite with attribution — see how the data is put together.